• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强直性脊柱炎活动期患者骨密度、骨转换标志物与维生素 D 状态的关系:横断面分析。

The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis.

机构信息

Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, P.O. Box 30001, 9700 RB Groningen, The Netherlands.

出版信息

Osteoporos Int. 2011 May;22(5):1431-9. doi: 10.1007/s00198-010-1338-7. Epub 2010 Jul 6.

DOI:10.1007/s00198-010-1338-7
PMID:20603707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3073049/
Abstract

SUMMARY

Osteoporosis is a well recognized complication of ankylosing spondylitis (AS). This study indicates that increased bone turnover, inflammation, and low vitamin D levels are important in the pathophysiology of AS-related osteoporosis, and that bone turnover markers (BTM) are valuable markers to detect bone loss in AS.

INTRODUCTION

The aim of this study was to elucidate the pathophysiology of AS-related osteoporosis by investigating the relation between bone mineral density (BMD), BTM, vitamin D, and clinical assessments of disease activity and physical function, as well as to identify parameters that are related to low BMD (osteopenia or osteoporosis) in AS patients with active disease.

METHODS

One hundred twenty-eight consecutive Dutch AS outpatients were included in this cross-sectional study. Bath AS Disease Activity Index (BASDAI), erythrocyte sedimentation rate (ESR), C-reactive protein, ASAS-endorsed disease activity score (ASDAS), Bath AS Functional Index (BASFI), bone formation markers procollagen type 1 N-terminal peptide (PINP) and osteocalcin (OC), bone resorption marker serum C-telopeptides of type I collagen (sCTX), 25-hydroxyvitamin D (25OHvitD), lumbar spine and hip BMD, and vertebral fractures were assessed. Z-scores of BTM were calculated using matched 10-year cohorts of a Dutch reference group to correct for the normal influence that age and gender have on bone turnover.

RESULTS

sCTX Z-score, OC Z-score, BASDAI, age, and gender were independently related to low BMD. In addition, PINP Z-score, ESR, 25OHvitD, age, and gender were independently related to sCTX and/or OC Z-score.

CONCLUSIONS

This study indicates that increased bone turnover, inflammation, and low vitamin D levels are important in the pathophysiology of AS-related osteoporosis. Furthermore, sCTX and OC Z-scores seem to be valuable markers to detect bone loss in AS patients in daily clinical practice where BMD of the lumbar spine, measured by DXA, may be overestimated due to osteoproliferation in patients with advanced AS.

摘要

摘要

骨质疏松症是强直性脊柱炎(AS)的一种公认并发症。本研究表明,骨转换增加、炎症和低维生素 D 水平在 AS 相关骨质疏松症的病理生理学中很重要,骨转换标志物(BTM)是检测 AS 患者骨丢失的有价值的标志物。

引言

本研究旨在通过研究骨密度(BMD)、BTM、维生素 D 与疾病活动和身体功能的临床评估之间的关系,阐明 AS 相关骨质疏松症的病理生理学,并确定与活动期 AS 患者低 BMD(骨质疏松或骨量减少)相关的参数。

方法

本横断面研究纳入了 128 例连续的荷兰 AS 门诊患者。评估了 Bath AS 疾病活动指数(BASDAI)、红细胞沉降率(ESR)、C 反应蛋白、ASAS 认可的疾病活动评分(ASDAS)、Bath AS 功能指数(BASFI)、骨形成标志物 1 型前胶原 N 端肽(PINP)和骨钙素(OC)、骨吸收标志物血清 I 型胶原 C 端肽(sCTX)、25-羟维生素 D(25OHvitD)、腰椎和髋部 BMD 以及椎体骨折。使用荷兰参考队列的 10 年匹配队列计算 BTM 的 Z 分数,以校正年龄和性别对骨转换的正常影响。

结果

sCTX Z 分数、OC Z 分数、BASDAI、年龄和性别与低 BMD 独立相关。此外,PINP Z 分数、ESR、25OHvitD、年龄和性别与 sCTX 和/或 OC Z 分数独立相关。

结论

本研究表明,骨转换增加、炎症和低维生素 D 水平在 AS 相关骨质疏松症的病理生理学中很重要。此外,sCTX 和 OC Z 分数似乎是检测 AS 患者骨丢失的有价值的标志物,在日常临床实践中,由于 AS 晚期患者的骨增生,DXA 测量的腰椎 BMD 可能会被高估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d24/3073049/7f8fe186ee4e/198_2010_1338_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d24/3073049/7f8fe186ee4e/198_2010_1338_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d24/3073049/7f8fe186ee4e/198_2010_1338_Fig1_HTML.jpg

相似文献

1
The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis.强直性脊柱炎活动期患者骨密度、骨转换标志物与维生素 D 状态的关系:横断面分析。
Osteoporos Int. 2011 May;22(5):1431-9. doi: 10.1007/s00198-010-1338-7. Epub 2010 Jul 6.
2
Higher bone turnover is related to spinal radiographic damage and low bone mineral density in ankylosing spondylitis patients with active disease: a cross-sectional analysis.骨转换增加与活动性强直性脊柱炎患者的脊柱影像学损伤及低骨密度相关:一项横断面分析。
PLoS One. 2014 Jun 11;9(6):e99685. doi: 10.1371/journal.pone.0099685. eCollection 2014.
3
The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.骨质疏松症与强直性脊柱炎中维生素 D 水平和疾病活动度的关系。
Rheumatol Int. 2010 Jan;30(3):375-81. doi: 10.1007/s00296-009-0975-7. Epub 2009 Aug 14.
4
Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study.强直性脊柱炎患者骨密度与疾病活动度和功能能力的关系:一项横断面研究。
Rheumatol Int. 2012 Sep;32(9):2801-8. doi: 10.1007/s00296-011-2066-9. Epub 2011 Aug 20.
5
Prevalence of osteoporosis and vertebral fractures and related factors in patients with ankylosing spondylitis.强直性脊柱炎患者骨质疏松症和椎体骨折的患病率及相关因素
Chin Med J (Engl). 2014;127(15):2740-7.
6
The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.中国某郊区绝经后女性骨转换标志物25(OH)D和甲状旁腺激素水平及其与骨密度的关系
Osteoporos Int. 2017 Jan;28(1):211-218. doi: 10.1007/s00198-016-3692-6. Epub 2016 Jul 28.
7
Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.巴勒斯坦绝经后骨质疏松症女性和正常女性的血清25-羟基维生素D及骨转换标志物
Arch Osteoporos. 2017 Dec;12(1):13. doi: 10.1007/s11657-017-0306-7. Epub 2017 Jan 26.
8
Association between bone turnover markers, clinical variables, spinal syndesmophytes and bone mineral density in Mexican patients with ankylosing spondylitis.墨西哥强直性脊柱炎患者骨转换标志物、临床变量、脊柱骨桥与骨密度之间的关联
Scand J Rheumatol. 2016 Nov;45(6):480-490. doi: 10.3109/03009742.2016.1152399. Epub 2016 May 24.
9
Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis.强直性脊柱炎中1,25-维生素D3缺乏、疾病活动度与低骨量的关联
Osteoporos Int. 2005 Dec;16(12):1999-2004. doi: 10.1007/s00198-005-1990-5. Epub 2005 Sep 20.
10
Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis.强直性脊柱炎女性的骨矿物质密度、跟骨超声及骨转换标志物
J Rheumatol. 2002 Mar;29(3):516-21.

引用本文的文献

1
Levels of osteocalcin and -terminal telopeptide of type I collagen in men with ankylosing spondylitis: associations with disease course and structural-functional status of bone tissue.强直性脊柱炎男性患者中骨钙素及I型胶原羧基末端肽水平:与疾病进程及骨组织结构-功能状态的关联
Reumatologia. 2025 Jun 20;63(3):144-151. doi: 10.5114/reum/201175. eCollection 2025.
2
The state of bone mineral density in men with ankylosing spondylitis and its relationship with the course of the disease.强直性脊柱炎男性患者的骨矿物质密度状况及其与疾病进程的关系。
Reumatologia. 2024;62(1):43-51. doi: 10.5114/reum/184028. Epub 2024 Mar 18.
3

本文引用的文献

1
The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.骨质疏松症与强直性脊柱炎中维生素 D 水平和疾病活动度的关系。
Rheumatol Int. 2010 Jan;30(3):375-81. doi: 10.1007/s00296-009-0975-7. Epub 2009 Aug 14.
2
Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis.强直性脊柱炎患者骨质疏松症和椎体骨折的患病率及危险因素
Bone. 2009 May;44(5):772-6. doi: 10.1016/j.bone.2008.12.028. Epub 2009 Jan 14.
3
Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study.
Causality between Ankylosing Spondylitis and osteoarthritis in European ancestry: a bidirectional Mendelian randomization study.
欧洲裔人群中强直性脊柱炎与骨关节炎之间的因果关系:一项双向孟德尔随机化研究。
Front Immunol. 2024 Feb 6;15:1297454. doi: 10.3389/fimmu.2024.1297454. eCollection 2024.
4
The prevalence of vertebral fractures in diffuse idiopathic skeletal hyperostosis and ankylosing spondylitis: A systematic review and meta-analysis.弥漫性特发性骨肥厚和强直性脊柱炎中椎体骨折的患病率:一项系统评价和荟萃分析。
N Am Spine Soc J. 2024 Jan 20;17:100312. doi: 10.1016/j.xnsj.2024.100312. eCollection 2024 Mar.
5
Serum levels of bone turnover markers including calculation of -scores: Data from a Dutch healthy reference cohort.血清骨转换标志物水平,包括T评分计算:来自荷兰健康参考队列的数据。
Bone Rep. 2023 Nov 12;19:101724. doi: 10.1016/j.bonr.2023.101724. eCollection 2023 Dec.
6
After an initial balance favoring collagen formation and mineralization, bone turnover markers return to pre-treatment levels during long-term TNF-α inhibition in patients with ankylosing spondylitis.在强直性脊柱炎患者接受长期 TNF-α 抑制治疗后,初始时有利于胶原形成和矿化的平衡状态会被打破,骨转换标志物的水平会恢复到治疗前的水平。
PLoS One. 2023 Mar 24;18(3):e0283579. doi: 10.1371/journal.pone.0283579. eCollection 2023.
7
Transcriptome-Wide Association Studies and Integration Analysis of mRNA Expression Profiles Identify Candidate Genes and Pathways Associated With Ankylosing Spondylitis.全转录组关联研究和 mRNA 表达谱的整合分析鉴定与强直性脊柱炎相关的候选基因和通路。
Front Immunol. 2022 May 10;13:814303. doi: 10.3389/fimmu.2022.814303. eCollection 2022.
8
Bone Involvement in Patients with Spondyloarthropathies.脊柱关节病患者的骨骼受累情况。
Calcif Tissue Int. 2022 Apr;110(4):393-420. doi: 10.1007/s00223-021-00933-1. Epub 2022 Jan 23.
9
The correlation between volumetric bone mineral density and morphological parameters of the proximal femur and clinical outcomes in ankylosing spondylitis patients with hip involvement.髋关节受累的强直性脊柱炎患者的容积骨密度与股骨近端形态参数的相关性及其与临床结局的关系。
BMC Musculoskelet Disord. 2022 Jan 3;23(1):24. doi: 10.1186/s12891-021-04912-3.
10
Prediction of Vertebral Fractures by Trabecular Bone Score in Patients With Ankylosing Spondylitis.强直性脊柱炎患者的骨小梁评分与椎体骨折的预测。
Physiol Res. 2021 Nov 30;70(Suppl 1):S53-S60. doi: 10.33549/physiolres.934774.
强直性脊柱炎与骨折风险:一项基于初级保健的大型巢式病例对照研究结果
Ann Rheum Dis. 2009 Dec;68(12):1839-42. doi: 10.1136/ard.2008.100503. Epub 2008 Dec 9.
4
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis.ASDAS,一种在强直性脊柱炎患者中经ASAS认可的具有高度鉴别力的疾病活动评分。
Ann Rheum Dis. 2009 Dec;68(12):1811-8. doi: 10.1136/ard.2008.100826. Epub 2008 Dec 5.
5
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.强直性脊柱炎患者中一种获得脊柱关节炎国际学会(ASAS)认可的疾病活动评分(ASDAS)的开发。
Ann Rheum Dis. 2009 Jan;68(1):18-24. doi: 10.1136/ard.2008.094870. Epub 2008 Jul 14.
6
Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis.
Rheumatology (Oxford). 2008 Aug;47(8):1219-22. doi: 10.1093/rheumatology/ken148. Epub 2008 Jun 6.
7
Bone and cartilage turnover markers, bone mineral density, and radiographic damage in men with ankylosing spondylitis.强直性脊柱炎男性患者的骨与软骨转换标志物、骨矿物质密度及影像学损害
Yonsei Med J. 2008 Apr 30;49(2):288-94. doi: 10.3349/ymj.2008.49.2.288.
8
Biomarkers of bone health and osteoporosis risk.骨骼健康和骨质疏松症风险的生物标志物。
Proc Nutr Soc. 2008 May;67(2):157-62. doi: 10.1017/S002966510800699X.
9
A reference standard for the description of osteoporosis.骨质疏松症描述的参考标准。
Bone. 2008 Mar;42(3):467-75. doi: 10.1016/j.bone.2007.11.001. Epub 2007 Nov 17.
10
Osteoporosis and vertebral fractures in ankylosing spondylitis.强直性脊柱炎中的骨质疏松症和椎体骨折
Curr Opin Rheumatol. 2007 Jul;19(4):335-9. doi: 10.1097/BOR.0b013e328133f5b3.